Centrexion Therapeutics

About:

Centrexion Therapeutics is a late clinical-stage biopharmaceutical company addressing the treatment of chronic pain.

Top Investors: Eli Lilly, New Enterprise Associates, ArrowMark Partners, InterWest Partners, Exome Asset Management

Description:

Centrexion Therapeutics is a late clinical-stage biopharmaceutical company focusing on identifying, developing, and commercializing non-opioid and non-addictive therapies to address the treatment of chronic pain.

Total Funding Amount:

$229M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)centrexion.com

Founders:

Kerrie Brady, Sol Barer

Number of Employees:

11-50

Last Funding Date:

2020-10-29

IPO Status:

Private

Industries: